Skip to content

An Assessment of the Risk of Cervical Cancer and Precancerous Lesions in Women with Negative Cytology and Positive Human Papillomavirus in Cervical Cancer Screening

An Assessment of the Risk of Cervical Cancer and Precancerous Lesions in Women with Negative Cytology and Positive Human Papillomavirus in Cervical Cancer Screening - An Assessment of the Risk of Cervical Cancer and Precancerous Lesions in Women with Negative Cytology and Positive Human Papillomavirus in Cervical Cancer Screening

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000061126
Enrollment
30000
Registered
2026-04-02
Start date
2025-06-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Women with a negative cytology (NILM) and positive high-risk HPV in cervical cancer screening

Interventions

None listed

Sponsors

Kagoshima University Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Women aged 30 to 65 who undergo cervical cancer screening in Kagoshima City and who have agreed to participate in this study. Excluded are women who are pregnant or who have been receiving treatment for cervical cancer or precancerous lesions during the past year.

Exclusion criteria

Exclusion criteria: Other than the above

Design outcomes

Primary

MeasureTime frame
Absolute risk of CIN 2 or higher in NILM/HPV(+)

Countries

Japan

Contacts

Public ContactShintaro Yanazume

Kagoshima University Hospital Department of Obstetrics and Gynecology

s-yana@m3.kufm.kagoshima-u.ac.jp0992755423

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026